Does IMATINIB Cause Therapy partial responder? 114 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 114 reports of Therapy partial responder have been filed in association with IMATINIB (Imatinib). This represents 0.3% of all adverse event reports for IMATINIB.
114
Reports of Therapy partial responder with IMATINIB
0.3%
of all IMATINIB reports
13
Deaths
19
Hospitalizations
How Dangerous Is Therapy partial responder From IMATINIB?
Of the 114 reports, 13 (11.4%) resulted in death, 19 (16.7%) required hospitalization, and 4 (3.5%) were considered life-threatening.
Is Therapy partial responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IMATINIB. However, 114 reports have been filed with the FAERS database.
What Other Side Effects Does IMATINIB Cause?
Death (9,708)
Drug ineffective (2,628)
Nausea (2,379)
Diarrhoea (2,203)
Fatigue (1,810)
Malignant neoplasm progression (1,716)
Vomiting (1,599)
Malaise (1,361)
Drug intolerance (1,354)
Drug resistance (1,293)
What Other Drugs Cause Therapy partial responder?
CYCLOPHOSPHAMIDE (1,397)
RITUXIMAB (1,219)
DEXAMETHASONE (1,199)
PREDNISONE (1,176)
PEMBROLIZUMAB (1,125)
CARBOPLATIN (1,096)
DOXORUBICIN (834)
METHOTREXATE (775)
VINCRISTINE (707)
ETOPOSIDE (670)
Which IMATINIB Alternatives Have Lower Therapy partial responder Risk?
IMATINIB vs IMBRUVICA
IMATINIB vs IMDEVIMAB
IMATINIB vs IMEGLIMIN
IMATINIB vs IMETELSTAT
IMATINIB vs IMIDAPRIL